Reaching the hard to reach: Characteristics of patients who received a COVID-19 vaccine in the emergency department.

2021 
In February 2021, the U.S. Food and Drug Administration (FDA) provided Emergency Use Authorization for the Janssen vaccine- the first one-dose COVID-19 vaccine to become available in the U.S. The one-dose regimen expanded opportunity to vaccinate in settings that can reach vulnerable communities for which returning to a site for a second vaccine dose may prove difficult. With 139 million visits annually in the U.S.1 and a tendency to serve in a safety net capacity for underserved patients2 , the emergency department (ED) is one such setting.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    4
    References
    0
    Citations
    NaN
    KQI
    []